Latin American consensus on uncomplicated recurrent urinary tract infection—2018

Simple item page
dc.contributor.authorMilhem Haddad, Jorge
dc.contributor.authorUbertazzi, Enrique
dc.contributor.authorStorme Cabrera, Oscar
dc.contributor.authorMedina, Martha
dc.contributor.authorGarcia, Jorge
dc.contributor.authorRodriguez-Colorado, Silvia
dc.contributor.authorToruno, Efrain
dc.contributor.authorKatsumi Matsuoka, Priscila
dc.contributor.authorCastillo-Pino, Edgardo
dc.date.accessioned2021-10-25T17:43:01Z
dc.date.available2021-10-25T17:43:01Z
dc.date.issued2020
dc.description.abstractAn estimated 20–30% of adult women who experience an initial urinary tract infection (UTI) will have recurrent infection. In these patients, prophylaxis may be considered to improve their quality of life and control overuse of antibiotics. Despite this need, there is currently no Latin American consensus on the treatment and prophylaxis of recurrent UTIs. This consensus, signed by a panel of regional and international experts on UTI management, aims to address this need and is the first step toward a Latin American consensus on a number of urogynecological conditions. The panel agrees that antibiotics should be considered the primary treatment option for symptomatic UTI, taking into account local pathogen resistance patterns. Regarding prophylaxis, immunoactive therapy with the bacterial lysate OM-89 received a grade A recommendation and local estrogen in postmenopausal women grade B recommendation. Lower-grade recommendations include behavior modification and D-mannose; probiotics (Lactobacilli), cranberries, and hyaluronic acid (and derivatives) received limited recommendations; their use should be discussed with the patient. Though considered effective and receiving grade A recommendation, antimicrobial prophylaxis should be considered only following prophylaxis with effective non-antimicrobial measures that were not successful and chosen based on the frequency of sexual intercourse and local pathogen resistance patterns.es
dc.identifier.citationInternational Urogynecology Journal (2020) 31:35–44es
dc.identifier.urihttps://doi.org/10.1007/s00192-019-04079-5es
dc.identifier.urihttp://hdl.handle.net/11447/4906
dc.language.isoenes
dc.subjectCystitises
dc.subjectRecurrentuncomplicatedUTIes
dc.subjectImmunotherapyes
dc.subjectProphylaxises
dc.subjectAntimicrobial resistancees
dc.subjectNon-antimicrobial prophylaxis Introductiones
dc.titleLatin American consensus on uncomplicated recurrent urinary tract infection—2018es
dc.typeArticlees

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Latin American consensus on uncomplicated recurrent urinary tract infection—2018.pdf
Size:
721.9 KB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services